An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Revolution Medicines, Inc.
Engeneic Pty Limited
Hoffmann-La Roche
Revolution Medicines, Inc.
Boston Scientific Corporation
BeiGene
Imunon
Advaxis, Inc.
Hoffmann-La Roche
Novartis
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Aragon Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Celgene
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Advanced Accelerator Applications
Isofol Medical AB
Jiangsu HengRui Medicine Co., Ltd.
Metabiomics Corp
Novartis
Exact Sciences Corporation
Merck KGaA, Darmstadt, Germany
Exact Sciences Corporation
Exact Sciences Corporation
Exact Sciences Corporation
Exact Sciences Corporation
AVEO Pharmaceuticals, Inc.
Bristol-Myers Squibb
BBB-Therapeutics B.V.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
AVEO Pharmaceuticals, Inc.
Pharmacyclics LLC.
Eli Lilly and Company
Medco Health Solutions, Inc.